Blog
Practical guidance on SBIR, STTR, and other non-dilutive funding from the BW&CO team. Read about agency programs, proposal strategy, compliance after award, and new funding opportunities for deep-tech, biotech, medtech, and defense founders.
NIH SBIR Funding Fell 17% in FY2026: What It Means for FY2027
NIH SBIR and STTR grant funding fell about 17% in FY2026 after the six-month program lapse. See what changed, what carries over to FY2027, and how to plan under the new nine-application cap.
SBIR and STTR Foreign Risk Review in 2026: What Reviewers Look For and What to Fix Before You Apply
The 2026 SBIR and STTR reauthorization expanded foreign risk reviews. Here is what reviewers check, which issues are real red flags, which are false alarms, and what to clean up before you apply.